Cargando…
Editorial Comment on “Performance of PRAME immunohistochemistry compared with that of c‐Kit, c‐Myc, or cyclin D1 for the diagnosis of acral melanocytic tumors”
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107274/ https://www.ncbi.nlm.nih.gov/pubmed/36575944 http://dx.doi.org/10.1111/pin.13298 |
| _version_ | 1785026569687793664 |
|---|---|
| author | Izumi, Miki |
| author_facet | Izumi, Miki |
| author_sort | Izumi, Miki |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10107274 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101072742023-04-18 Editorial Comment on “Performance of PRAME immunohistochemistry compared with that of c‐Kit, c‐Myc, or cyclin D1 for the diagnosis of acral melanocytic tumors” Izumi, Miki Pathol Int Editorial Comment John Wiley and Sons Inc. 2022-12-28 2023-01 /pmc/articles/PMC10107274/ /pubmed/36575944 http://dx.doi.org/10.1111/pin.13298 Text en © 2022 The Authors. Pathology International published by Japanese Society of Pathology and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Editorial Comment Izumi, Miki Editorial Comment on “Performance of PRAME immunohistochemistry compared with that of c‐Kit, c‐Myc, or cyclin D1 for the diagnosis of acral melanocytic tumors” |
| title | Editorial Comment on “Performance of PRAME immunohistochemistry compared with that of c‐Kit, c‐Myc, or cyclin D1 for the diagnosis of acral melanocytic tumors” |
| title_full | Editorial Comment on “Performance of PRAME immunohistochemistry compared with that of c‐Kit, c‐Myc, or cyclin D1 for the diagnosis of acral melanocytic tumors” |
| title_fullStr | Editorial Comment on “Performance of PRAME immunohistochemistry compared with that of c‐Kit, c‐Myc, or cyclin D1 for the diagnosis of acral melanocytic tumors” |
| title_full_unstemmed | Editorial Comment on “Performance of PRAME immunohistochemistry compared with that of c‐Kit, c‐Myc, or cyclin D1 for the diagnosis of acral melanocytic tumors” |
| title_short | Editorial Comment on “Performance of PRAME immunohistochemistry compared with that of c‐Kit, c‐Myc, or cyclin D1 for the diagnosis of acral melanocytic tumors” |
| title_sort | editorial comment on “performance of prame immunohistochemistry compared with that of c‐kit, c‐myc, or cyclin d1 for the diagnosis of acral melanocytic tumors” |
| topic | Editorial Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107274/ https://www.ncbi.nlm.nih.gov/pubmed/36575944 http://dx.doi.org/10.1111/pin.13298 |
| work_keys_str_mv | AT izumimiki editorialcommentonperformanceofprameimmunohistochemistrycomparedwiththatofckitcmycorcyclind1forthediagnosisofacralmelanocytictumors |